Tim
Sandle has written an article looking at the impact of Brexit on European
pharmaceutical companies.
Here
is the introduction:
Companies
who market pharmaceuticals in the European Union and in the U.K. will need to
plan and make decisions in advance of the U.K.’s departure from the European
Union in March 2019. Here companies need to decide whether they shift operation
to Europe; or maintain a U.K. and European base; or exit the U.K. entirely.
These decisions are not helped by the current cloud of political uncertainty
and indecisiveness from the government.”
The
reference is:
Sandle,
T. (2018) Brexit uncertainty for pharmaceutical companies, Pharmig News, Issue 72, pp5-6
No comments:
Post a comment
Pharmaceutical Microbiology Resources